Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

Sector

Healthcare Facilities & Services

More about the company

11/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	5.67Cr 6.56Cr 5.22Cr 4.89Cr 9.16Cr 623.66Cr 9.3Cr 62Cr 24Cr 303.56Cr 25Cr 24Cr 1.05TCr	P/E Ratio 2024	44.3x	P/E Ratio 2025	31.3x
Enterprise Value	5.68Cr 6.58Cr 5.23Cr 4.9Cr 9.18Cr 625.03Cr 9.32Cr 62Cr 24Cr 304.23Cr 25Cr 24Cr 1.05TCr	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

11/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
11/06	Klea Holding announces the launch of its new subsidiary
23/04	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/04	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
01/04	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
19/01	Klea Holding Increases Annual Revenue by 28%
19/01	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
19/01	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/25/27	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/25/27	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
19/25/19	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/25/18	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

11/06	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
23/04	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
23/04	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
01/04	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
19/01	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

12/06	Klea Holding : Déclaration des transactions sur actions propres
11/06	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
11/06	Klea Holding annonce le démarrage de sa nouvelle filiale
11/06	Une bonne grosse purge avant SpaceX
11/06	Klea Holding : Klea Pharmaceuticals annonce le démarrage de son activité avec un puissant partenaire

VISD GP Share Price Swiss Exchange

Stocks

OXVMG

FR0011067669

Healthcare Facilities & Services

Valuation: VISD GP

Latest news : VISD GP

Analysts' recommendations: VISD GP

Press Releases: VISD GP

News in other languages: VISD GP

Managers and Directors: VISD GP

Other Healthcare Facilities & Services

Financials

Company Profile

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	+1.47%	+6.29%	+51.14%	+52.98%	13TCr
HCA HEALTHCARE, INC.	+2.29%	+4.04%	+4.31%	+36.24%	8.59TCr
FRESENIUS SE & CO. KGAA	+1.13%	+1.10%	-14.39%	+47.32%	2.46TCr
QUEST DIAGNOSTICS INCORPORATED	-0.38%	+1.38%	+12.68%	+49.03%	2.25TCr
LABCORP HOLDINGS INC.	+0.34%	+0.38%	+1.93%	+17.26%	2.18TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.69%	+0.93%	-14.00%	-21.09%	1.98TCr
TENET HEALTHCARE CORPORATION	+0.86%	+7.77%	+6.26%	+125.43%	1.5TCr
REDE D'OR SÃO LUIZ S.A.	+0.12%	+4.03%	-2.91%	+2.22%	1.48TCr
DAVITA INC.	+2.37%	+8.59%	+53.29%	+114.05%	1.34TCr
Average	+1.10%	+3.58%	+10.92%	+47.05%	3.87TCr
Weighted average by Cap.	+1.42%	+4.30%	+21.51%	+45.06%

	2024	2025
Net sales	1.73Cr 2Cr 1.59Cr 1.49Cr 2.79Cr 189.95Cr 2.83Cr 19Cr 7.32Cr 92Cr 7.5Cr 7.34Cr 320.12Cr	2.22Cr 2.57Cr 2.04Cr 1.91Cr 3.58Cr 243.94Cr 3.64Cr 24Cr 9.4Cr 118.73Cr 9.63Cr 9.43Cr 411.11Cr
Net income	14.05L 16.27L 12.95L 12.12L 22.71L 15Cr 23.06L 1.53Cr 59.6L 7.53Cr 61.05L 59.75L 26Cr	22.81L 26.41L 21.02L 19.68L 36.87L 25Cr 37.44L 2.48Cr 96.77L 12Cr 99.12L 97.01L 42Cr
Net Debt	25.75L 29.81L 23.73L 22.21L 41.63L 28Cr 42.27L 2.8Cr 1.09Cr 14Cr 1.12Cr 1.1Cr 48Cr	1L 1L 1L 1L 2L 1.38Cr 2L 13.6L 5L 66.96L 5L 5L 2.32Cr

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-